News | October 29, 2014

Tomosynthesis Improves Cancer Detection in Women with Dense Breast Tissue

New study shows cost-effectiveness for combining digital mammography and tomosynthesis when screening women with dense breasts

October 29, 2014 — As of October 2014, 19 states have enacted laws requiring women to be directly informed if they have dense breasts and would benefit from supplemental screening. However, the recommended type of supplemental screening for women with dense breasts remains unclear. With 15 additional states considering similar laws and federal legislation introduced, physician scientists at the University of Washington and Seattle Cancer Care Alliance (SCCA) investigated the potential impact of supplemental screening for women with dense breast tissue. The study’s findings are published this month online in the journal Radiology.

The study found that adding tomosynthesis (3-D mammography) to routine biennial digital mammography screening among U.S. women with dense breasts could improve health outcomes at a reasonable cost relative to digital mammography screening alone. This is the first comparative effectiveness study performed at the national level using an established model, and it could influence future screening recommendations for women with dense breast tissue who comprise nearly half of all women in the United States.

“We felt that this analysis would help inform timely policy and practice decisions given both increased attention to screening for women with dense breasts and rapid adoption of tomosynthesis in routine practice,” said Christoph I. Lee, M.D., M.S.H.S., lead author of the study, assistant professor in the Department of Radiology and Health Services at the University of Washington and staff radiologist at SCCA. “While screening ultrasound is currently being touted as the additional test of choice for women with dense breasts, it requires significant increases in manpower and leads to a larger number of false positives. Digital breast tomosynthesis, in contrast to ultrasound, offers operational and ease-of-use advantages since it is an integrated part of newer-generation mammography units.”

Mammography remains the only screening test proven to decrease mortality from breast cancer. However, mammography is less accurate in women with dense breasts for whom cancers may be masked by overlapping breast tissue. Moreover, dense breasts compared to average-density breasts are associated with a moderate increased relative risk for developing breast cancer independent of the masking effect. Given that nearly half of the U.S. screening population has dense breasts, an increasingly large number of women may be encouraged to consider supplemental screening beyond conventional mammography.

According to Constance Lehman, M.D., Ph.D., chief of breast imaging at the University of Washington, and director of imaging at Seattle Cancer Care Alliance, “Prior research has reported improved diagnostic accuracy with tomosynthesis, with both fewer false positives and higher cancer detection rates. However, until this study, we had little understanding of the impact of that improved performance on patient outcomes and costs.”

For this study, researchers used a breast cancer simulation model previously used to guide the U.S. Preventive Services Task Force recommendations for breast cancer screening. The team estimated the comparative clinical effectiveness and cost effectiveness of biennial screening with both digital mammography and tomosynthesis versus digital mammography alone among U.S. women ages 50 to 74 years with dense breasts, using data and metrics from the National Cancer Institute’s Breast Cancer Surveillance Consortium, Medicare reimbursement rates and medical literature. They found that one breast cancer death would be prevented and 810 false-positive exams avoided per 2,000 women screened over 12 rounds of screening, and that the incremental cost per quality-adjusted life year (QALY) gained by adding tomosynthesis to digital mammography screening was $53,893, well below the established threshold for cost effectiveness ($100,000 per QALY gained).

“The population outcomes we report show the promise of tomosynthesis, but it is critical to emphasize the need for primary data on tomosynthesis performance in U.S. community settings,” said Anna Tosteson, Sc.D., a co-author and James J. Carroll Professor at the Geisel School of Medicine at Dartmouth. “As such evidence becomes available, population modeling will be needed to elucidate the most clinically effective and efficient approaches to screening women with mammographically dense breast tissue.”

The study team currently uses effectiveness data from European trials to estimate the effects of adding tomosynthesis among the U.S. population. “While this modeling study suggests that there is a high likelihood that breast tomosynthesis will be cost-effective in the United States, further primary data from ongoing and planned studies will be very important to reduce uncertainty regarding the model estimates,” said Scott Ramsey, M.D., Ph.D., another study co-author and co-director of the Hutchinson Institute for Cancer Outcomes Research.

“Overall, this study provides women, physicians, payers and policymakers in the United States with much needed information regarding the balance between potential benefits and harms of combined mammography and tomosynthesis screening for women with dense breast tissue,” Lee said.

For more information: www.seattlecca.org

Related Content

MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area

NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area. Image courtesy of David Vaillancourt, Ph.D., University of Florida.

News | Neuro Imaging | July 31, 2017
Scientists at the University of Florida have discovered a new method of observing the brain changes caused by Parkinson...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
"Residual Echo" of Ancient Humans May Hold Clues to Mental Disorders

MRI data shows (left) areas of the skull preferentially affected by the amount of Neanderthal-derived DNA and (right) areas of the brain’s visual system in which Neanderthal gene variants influenced cortex folding (red) and gray matter volume (yellow). Image courtesy of Michael Gregory, M.D., NIMH Section on Integrative Neuroimaging

News | Neuro Imaging | July 26, 2017
Researchers from the National Institute of Mental Health (NIMH) have produced the first direct evidence that parts of...
New York Hospital Finds Significant Cost Savings With Toshiba’s Aquilion One CT
News | Computed Tomography (CT) | July 25, 2017
In five years, Kaleida Health’s Stroke Care Center (SCC) at the Gates Vascular Institute in Buffalo, N.Y., has realized...
Overlay Init